Page last updated: 2024-08-23

escitalopram and Parkinson Disease

escitalopram has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brown, R; Carroll, C; Duncan, G; Freemantle, N; Grover, L; Hunter, R; Lewis, G; Molloy, S; Schrag, A; Serfaty, MA; Whipps, J	1

Trials

1 trial(s) available for escitalopram and Parkinson Disease

Article	Year
Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease. BMC neurology, 2022, Dec-12, Volume: 22, Issue:1 Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Multicenter Studies as Topic; Nortriptyline; Parkinson Disease; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2022

Article

Year

Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.

BMC neurology, 2022, Dec-12, Volume: 22, Issue:1

Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Escitalopram; Humans; Multicenter Studies as Topic; Nortriptyline; Parkinson Disease; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome

2022